Medical Sciences Forum, Volume 43, 2026

IECMD 2025 - 4 articles

The 2nd International Electronic Conference on Medicine

Online | 11–13 November 2025

Volume Editors:
Alberto Ouro, Health Research Institute of Santiago de Compostela, Spain;
Clinical University Hospital (CHUS), SERGAS, Santiago de Compostela, Spain
Allison B. Reiss, New York University Long Island School of Medicine, Mineola, New York, USA

Cover Story: The 2nd International Electronic Conference on Medicine—Exploring Cutting-Edge Discoveries in Neurology (IECMD 2025) was held online from 11 to 13 November 2025. The conference brought together clinicians, scientists, and researchers worldwide to share recent advances, discuss ongoing challenges, and explore future directions in neurological research and clinical practice. Contributions covered a wide range of topics, including neurodegeneration, dementia spectrum disorders, stroke and brain injury, sleep disorders, and chronic pain, fostering meaningful dialogue, innovation, and international collaboration across the field of clinical neuroscience.

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

Select all

Sort by

Proceeding Paper

1,141 Views

20 Pages

Multiple Sclerosis and Occupational Outcomes in the COVID-19 Era: A Scoping Review

Ioannis Adamopoulos,
Aida Vafae Eslahi,
Niki Syrou,
Maad M. Mijwil and
Panagiotis Tsirkas

Med. Sci. Forum2026, 43(1), 4;https://doi.org/10.3390/msf2026043004

4 March 2026

The coronavirus disease 2019 (COVID-19) pandemic has disrupted both health and occupational functioning in participants with multiple sclerosis (PwMS). This review synthesizes evidence from 55 studies (30,830 PwMS) on psychological, social, and work-...

Full Article

Proceeding Paper

5,025 Views

9 Pages

The Effects of Therapeutic Cannabis and Cannabinoids in Parkinson’s Disease: An Overview of Meta-Analyses

Michele Antonelli,
Elena Mazzoleni and
Davide Donelli

Med. Sci. Forum2026, 43(1), 3;https://doi.org/10.3390/msf2026043003

20 February 2026

Background. Cannabis and cannabinoids have been investigated for their potential therapeutic effects in Parkinson’s disease, but clinical research findings remain scant and inconsistent. This study provides a systematic overview of peer-reviewe...

Full Article

Proceeding Paper

1,853 Views

8 Pages

The Impact of Neuropsychiatric Symptoms in Early-Stage Alzheimer’s Disease and Mild Cognitive Impairment

Donna de Levante Raphael

Med. Sci. Forum2026, 43(1), 2;https://doi.org/10.3390/msf2026043002

12 February 2026

Background: Alzheimer’s disease (AD) and mild cognitive impairment (MCI) are traditionally defined by progressive cognitive decline, yet neuropsychiatric symptoms (NPS), including depression, apathy, anxiety, irritability, and sleep disturbance...

Full Article

Proceeding Paper

1 Citations

5,821 Views

9 Pages

From Sweeteners to Sleeplessness: The Hidden Effects of Sucralose and Saccharin on the Gut–Brain Axis

Anxo Carreira-Casais and
Antia G. Pereira

Med. Sci. Forum2026, 43(1), 1;https://doi.org/10.3390/msf2026043001

20 January 2026

Sweetener consumption has increased considerably in recent decades, driven by the growing demand from consumers of low-calorie products for weight control and, especially, from diabetic patients who require safe sweetener alternatives without affecti...

Full Article

Med. Sci. Forum - ISSN 2673-9992

Imprint

Download Flyer